天美传媒

Abstract

Pancreatic islet transplantation has emerged as a promising therapy for Type-1 Diabetes (T1D), offering the potential for insulin independence and improved glycemic control. Despite significant advancements in islet isolation, transplantation techniques, and immunosuppressive regimens, several challenges persist, limiting the widespread adoption and long-term success of this therapeutic approach. This article reviews the current state of pancreatic islet transplantation for T1D, highlighting recent advancements, ongoing challenges, and future directions for improving outcomes and expanding access to this life-changing therapy.